readthroughSign in
CompanyCRSPNasdaqZug

CRISPR Therapeutics AG

CRISPR Therapeutics develops CRISPR/Cas9-based therapies for genetic diseases through a collaboration with Vertex.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 13Latest story